Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial

2018 ◽  
Vol 67 (11) ◽  
pp. 1777-1788 ◽  
Author(s):  
Yu Yao ◽  
Feifei Luo ◽  
Chao Tang ◽  
Dikang Chen ◽  
Zhiyong Qin ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dendritic Cell ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Molecular Subgroups ◽  
Expression Levels ◽  
Randomized Phase Ii ◽  
Dendritic Cell Vaccines

Early selection in a randomized phase II clinical trial

2002 ◽  
Vol 21 (12) ◽  
pp. 1711-1726 ◽  
Author(s):  
Seth M. Steinberg ◽  
David J. Venzon
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Early Selection ◽  
Randomized Phase Ii

scholarly journals A Bayesian pick-the-winner design in a randomized phase II clinical trial

Oncotarget ◽  
2017 ◽  
Vol 8 (51) ◽  
pp. 88376-88385
Author(s):  
Dung-Tsa Chen ◽  
Po-Yu Huang ◽  
Hui-Yi Lin ◽  
Alberto A. Chiappori ◽  
Dmitry I. Gabrilovich ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Randomized Phase Ii

scholarly journals Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial

2012 ◽  
Vol 28 (4) ◽  
pp. 1131-1138 ◽  
Author(s):  
CHIE OSHITA ◽  
MASAKO TAKIKAWA ◽  
AKIKO KUME ◽  
HARUO MIYATA ◽  
TADASHI ASHIZAWA ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dendritic Cell ◽  
Metastatic Melanoma ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Melanoma Patients

scholarly journals P08.09 Axitinib for the treatment of patients with recurrent glioblastoma, final results from a randomized phase II clinical trial

2016 ◽  
Vol 18 (suppl_4) ◽  
pp. iv41-iv42
Author(s):  
J. Duerinck ◽  
S. Du Four ◽  
F. Bouttens ◽  
V. Verschaeve ◽  
C. Andre ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Recurrent Glioblastoma ◽  
Phase Ii Clinical Trial ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document